Trial
NCT01260467
Memantine for Recurrent Glioblastoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Rochester
Collaborators
—
Condition
Glioblastoma
Intervention
memantine
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-10